Camden Capital, LLC Pfizer Inc Transaction History

Camden Capital, LLC

$887 Million
Q4 2024

A detailed history of Camden Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Camden Capital, LLC holds 150,810 shares of PFE stock, worth $3.84 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

150,810

Previous 55,742 170.55%

Holding current value

$3.84 Million

Previous $1.61 Million 147.99%

% of portfolio

0.45%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	BUY	$24.8 - $30.19 $2.36 Million - $2.87 Million	95,068 Added 170.55%	150,810 $4 Million
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $217,500 - $246,474	7,852 Added 16.4%	55,742 $1.61 Million
Q2 2024 Aug 06, 2024	SELL	$25.26 - $29.6 $477,590 - $559,647	-18,907 Reduced 28.31%	47,890 $1.34 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $68,246 - $78,368	2,636 Added 4.11%	66,797 $1.85 Million
Q4 2023 Feb 05, 2024	BUY	$26.13 - $33.94 $751,289 - $975,842	28,752 Added 81.2%	64,161 $1.85 Million
Q3 2023 Nov 03, 2023	SELL	$32.09 - $37.51 $378,405 - $442,317	-11,792 Reduced 24.98%	35,409 $1.17 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $214,083 - $247,689	5,927 Added 14.36%	47,201 $1.73 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $24,224 - $31,537	615 Added 1.51%	41,274 $1.68 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $1.24 Million - $1.62 Million	29,753 Added 272.81%	40,659 $2.08 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $90,670 - $110,686	2,072 Added 23.45%	10,906 $477,000
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $28,848 - $34,205	620 Added 7.55%	8,834 $463,000
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $45,658 - $56,576	998 Added 13.83%	8,214 $425,000
Q4 2021 Feb 28, 2022	SELL	$41.32 - $61.25 $382,953 - $567,665	-9,268 Reduced 56.22%	7,216 $426,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $60,988 - $90,405	-1,476 Reduced 8.22%	16,484 $973,000
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $206,965 - $265,864	5,273 Added 41.56%	17,960 $772,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $29,015 - $32,869	808 Added 6.8%	12,687 $497,000
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $67,683 - $76,333	2,021 Added 20.5%	11,879 $430,000
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $82,704 - $105,165	2,471 Added 33.45%	9,858 $363,000
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $234,537 - $275,165	7,387 New	7,387 $271,000
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $212,346 - $257,607	-7,050 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$27.03 - $38.62 $66,304 - $94,734	-2,453 Reduced 25.81%	7,050 $230,000
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $312,838 - $355,032	9,503 New	9,503 $372,000

Others Institutions Holding PFE

# of Institutions

3,273

Shares Held

3.72B

Call Options Held

77.2M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Pfizer Inc Transaction History